期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
基于类药有效组分特征图谱的中药复方质量表征模式研究 被引量:22
1
作者 戴莹 姜艳艳 +5 位作者 刘洋 巴寅颖 吕航 闫陶 陈小虎 石任兵 《北京中医药大学学报》 CAS CSCD 北大核心 2011年第5期326-332,共7页
目的以开心散为研究载体,建立基于类药有效组分特征图谱的中药复方质量表征模式。方法采用东莨菪碱造模致SD大鼠记忆障碍,灌胃给予开心散提取物,取含药血清;同时采用改良的外翻肠囊法,制备开心散小肠吸收液,测定HPLC特征图谱,并与开心... 目的以开心散为研究载体,建立基于类药有效组分特征图谱的中药复方质量表征模式。方法采用东莨菪碱造模致SD大鼠记忆障碍,灌胃给予开心散提取物,取含药血清;同时采用改良的外翻肠囊法,制备开心散小肠吸收液,测定HPLC特征图谱,并与开心散提取物HPLC特征图谱进行对比分析。结果筛选出开心散类药有效组分中14个化学成分,鉴定了其中的5个特征成分,进而采用血清药理方法对所筛选的类药有效组分进行药效验证,并进一步建立类药有效组分特征图谱,形成基于类药有效组分特征图谱的开心散质量表征模式。结论所建立的基于类药有效组分特征图谱的中药复方质量表征模式,科学、合理、可行,更能体现中药复方质量特性,可作为中药复方质量控制研究的一种新思路与方法。 展开更多
关键词 有效组分 类药筛选 特征图谱 质量表征模式 开心散
原文传递
Identification of Potential Flavonoid Inhibitors of the SARS-CoV-2 Main Protease 6YNQ:A Molecular Docking Study 被引量:3
2
作者 SUMIT Arora GOVIND Lohiya +2 位作者 KESHAV Moharir SAPAN Shah SUBHASH Yende 《Digital Chinese Medicine》 2020年第4期239-248,共10页
Objective Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2),the causative agent for coronavirus disease 2019(COVID-19),is responsible for the recent global pandemic.As there are no effective drugs or vaccine... Objective Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2),the causative agent for coronavirus disease 2019(COVID-19),is responsible for the recent global pandemic.As there are no effective drugs or vaccines available for SARS-CoV-2,we investigated the potential of flavonoids against SARS-CoV-2 main protease 6YNQ.Methods In silico molecular simulation study against SARS-CoV-2 main protease 6YNQ.Results Among the 21 selected flavonoids,rutin demonstrated the highest binding energy(−8.7 kcal/mol)and displayed perfect binding with the catalytic sites.Conclusions Our study demonstrates the inhibitory potential of flavonoids against SARS-CoV-2 main protease 6YNQ.These computational simulation studies support the hypothesis that flavonoids might be helpful for the treatment of COVID-19. 展开更多
关键词 COVID-19 SARS-CoV-2 Protease 6YNQ In silico Molecular simulation Virtual drug screening FLAVONOIDS
下载PDF
Limitations of the use of MTT assay for screening in drug discovery 被引量:4
3
作者 韩梅 李金凤 +2 位作者 谭祺 孙媛媛 王永炎 《Journal of Chinese Pharmaceutical Sciences》 CAS 2010年第3期195-200,共6页
The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay is a routine cell viability assay for cell proliferation and cytotoxicity, which is widely used in many fields, especially in screening... The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay is a routine cell viability assay for cell proliferation and cytotoxicity, which is widely used in many fields, especially in screening for drug discovery. However, this assay exhibits limitations in the presence of particular compounds and under certain assay conditions, which may yield false screening results. For example, polyphenols that are extracted from natural sources can react with MTT in the absence of living cells and thus interfere with the screening results. We measured the absorbance of 15 polyphenols extracted from green tea and showed that the phenolic hydroxyl groups in the polyphenols are responsible for the reduction of MTT to formazan. When three or more phenolic hydroxyl groups were present on a conjugated polyphenol, a significantly increased MTT reduction was observed. Moreover, the type of medium also had an effect on the absorbance value, in the following order: ct-MEM + 10% FBS〉 a-MEM〉DMEM/F12〉PBS. The absorbance of the MTT assay recorded at 570 nm is more sensitive than that measured at 595 nm. These results will improve the cell-based assay of polyphenols and clarify the limitations of the MTT assay as a method of screening in drug discovery. 展开更多
关键词 MTTassay Po(yphenols Drug discovery SCREENING
原文传递
Comparative pharmacophore modeling of human adenosine receptor A1 and A3 antagonists
4
作者 XU ZheJun CHENG FeiXiong +5 位作者 LI Jie ZHOU YaDi SU Ni LI WeiHua LIU GuiXia TANG Yun 《Science China Chemistry》 SCIE EI CAS 2012年第11期2407-2418,共12页
Adenosine receptors are promising therapeutic targets in drug discovery. In this study, three-dimensional pharmacophore mod- els of human adenosine receptor A1 and A3 antagonists were developed based on 26 and 23 dive... Adenosine receptors are promising therapeutic targets in drug discovery. In this study, three-dimensional pharmacophore mod- els of human adenosine receptor A1 and A3 antagonists were developed based on 26 and 23 diverse compounds, respectively. The best A1 pharmacophore model (A1-Hopyl) consists of four features: one hydrogen bond donor, one hydrophobic point and two ring aromatics, while the best A3 pharmacophore model (A3_Hopyl) also has four features: one hydrogen bond ac- ceptor, one hydrophobic point and two ring aromatics. The correlation coefficients were 0.840 for A1 test set with 146 diverse compounds and 0.827 for A3 test set with 238 diverse compounds. In the simulated virtual screening experiments, high en- richment factors of 6.51 and 6.90 were obtained for A1_Hopyl and A3_Hopyl models, respectively. Moreover, two models also showed high subtype-selectivity in the simulated virtual screening experiments. These results could be helpful for the dis- covery of novel potent and selective A1 and A3 antagonists. 展开更多
关键词 pharmacophore modeling adenosine receptors ANTAGONISTS enrichment factor simulated virtual screening
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部